Skip to content
Recall Observatory FDA recall evidence

Drug product

Amoxicillin for Oral Suspension USP, 125 mg per 5 mL, packaged in a 100 mL bottle, Rx only, Manufactured for: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960, NDC 0093-4150-73

D-0440-2017

December 21, 2016

Class II

Product summary

Firm
Teva Pharmaceuticals USA
Event
Event 76038
Status
Terminated
Classification
Class II
Quantity
133,601 bottles
Official record key
drug-enforcement:D-0440-2017

Official wording

Reason: Subpotency: due to a low, out of specification test result for assay during stability testing.

Code information: Lot # 35432507A, 35434914A, 35435798A, 35437490A, Exp 9/19

Distribution pattern: United States and Puerto Rico

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotency